Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Insmed Inc (INSM)

36.99   -0.4 (-1.07%) 10-24 14:23
Open: 37.7 Pre. Close: 37.39
High: 37.94 Low: 36.69
Volume: 454,683 Market Cap: 3,754M
Insmed, Inc. is a biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 373 full-time employees. The Company’s product ARIKAYCE (amikacin liposome inhalation suspension) is developed for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The firm's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that offers a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 37.996 - 38.187 38.187 - 38.345
Low: 36.253 - 36.453 36.453 - 36.618
Close: 36.697 - 37.01 37.01 - 37.269

Technical analysis

as of: 2020-10-23 4:45:23 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 46.01     One year: 53.74
Support: Support1: 34.58    Support2: 31.60
Resistance: Resistance1: 39.39    Resistance2: 46.01
Pivot: 35.95
Moving Average: MA(5): 37.35     MA(20): 35.12
MA(100): 29.69     MA(250): 25.44
MACD: MACD(12,26): 1.57     Signal(9): 1.55
Stochastic oscillator: %K(14,3): 67.99     %D(3): 76.98
RSI: RSI(14): 60.96
52-week: High: 39.39  Low: 12.09  Change(%): 106.4
Average Vol(K): 3-Month: 81033  10-Days: 64482

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INSM has closed below upper band by 32.0%. Bollinger Bands are 20.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 24 Oct 2020
Insmed Incorporated (INSM) has great growth outlook for 2020 - Marketing Sentinel

Thu, 22 Oct 2020
Insmed Incorporated (INSM) 14-day ATR is 1.76: This Stock is Set to Soar Above its Peers - News Daemon

Thu, 22 Oct 2020
Insmed Incorporated (INSM) Just Got Our Attention - The News Heater

Thu, 22 Oct 2020
Don’t Let Recent momentum Confuse Your Outlook on Insmed Incorporated [INSM] - MZP News

Wed, 21 Oct 2020
Insmed Inc. (INSM) Plunges 5.01% on October 21 -

Tue, 20 Oct 2020
Insmed Inc. (INSM) Breaks into New 52-Week High on October 20 Session -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101
Shares Float (M) 95
% Held by Insiders 1.26
% Held by Institutions 98.28
Shares Short (K) 11,600
Shares Short P. Month (K) 12,420

Stock Financials

EPS -2.650
EPS Est This Year -2.700
EPS Est Next Year -2.280
Book Value (p.s.) 4.000
Profit Margin -147.54
Operating Margin -132.99
Return on Assets (ttm) -16.1
Return on Equity (ttm) -63.5
Qtrly Rev. Growth 41.8
Gross Profit (p.s.) 1.106
Sales Per Share 1.616
EBITDA (p.s.) -2.087
Qtrly Earnings Growth
Operating Cash Flow (M) -191
Levered Free Cash Flow (M) -145

Stock Valuations

PE Ratio -13.96
PEG Ratio
Price to Book value 9.25
Price to Sales 22.90
Price to Cash Flow -19.69

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.